Position in HLN
as of Mar 31, 2026
· filed Apr 7, 2026
Position Value
$394,013
+$22,077 QoQ
Shares Held
39,362
+7.0% QoQ
Ownership
0.001%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Sep 2022
15 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in HLN Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - Specialty & Generic
Healthcare · as of Mar 31, 2026U.S. Capital Wealth Advisors, LLC holds $1,533,231 across 3 Drug Manufacturers - Specialty & Generic names. HLN ranks #2 (25.7% of the industry book) .
All Filings in HLN
Export CSV
15 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $394,013 | 39,362 | Shares | Sole | 2026-04-07 | |
| 2025-12-31 | $371,936 | 36,789 | Shares | Sole | 2026-01-23 | |
| 2025-09-30 | $326,131 | 36,358 | Shares | Sole | 2025-10-09 | |
| 2025-06-30 | $427,897 | 41,263 | Shares | Sole | 2025-07-14 | |
| 2025-03-31 | $1,071,796 | 104,159 | Shares | Sole | 2025-04-29 | |
| 2024-12-31 | $959,666 | 100,594 | Shares | Sole | 2025-01-24 | |
| 2024-09-30 | $1,059,809 | 100,171 | Shares | Sole | 2024-10-22 | |
| 2024-06-30 | $870,447 | 105,381 | Shares | Sole | 2024-07-11 | |
| 2024-03-31 | $921,445 | 108,533 | Shares | Sole | 2024-05-10 | |
| 2023-12-31 | $1,082,524 | 131,534 | Shares | Sole | 2024-02-06 | |
| 2023-09-30 | $1,124,683 | 135,016 | Shares | Sole | 2023-10-19 | |
| 2023-06-30 | $1,293,034 | 154,300 | Shares | Sole | 2023-08-04 | |
| 2023-03-31 | $1,484,263 | 182,342 | Shares | Sole | 2023-05-11 | |
| 2022-12-31 | $1,724,632 | 215,579 | Shares | Sole | 2023-02-03 | |
| 2022-09-30 | $1,619,873 | 265,989 | Shares | Sole | 2022-11-01 | |
| No filing history on record for this holder in this stock. | ||||||